Kiniksa Pharmaceuticals International, plc - COM CL A (KNSA)

Historical Portfolio Holders from Q2 2018 to Q2 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM CL A
Shares, excl. options Q1 2024
38.9 M
Holdings value Q1 2024
$768 M
Value change Q1 2024
+$97.1 M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
151
Number of buys Q1 2024
1
Number of sells Q1 2024
-6
Average buys Q1 2024 %
+0%
Average sells Q1 2024 %
-0.001%
CUSIP
G5269C101
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q2 1.33 K $24.3 K -$3.25 M $18.16 2
2024 Q1 38.9 M $768 M +$97.1 M $19.73 152
2023 Q4 34.2 M $600 M -$23.7 M $17.54 143
2023 Q3 34.9 M $606 M +$53.5 M $17.37 135
2023 Q2 31.8 M $448 M +$7.26 M $14.08 126
2023 Q1 31.5 M $339 M +$11.6 M $10.76 130
2022 Q4 29.8 M $446 M +$8.87 M $14.98 122
2022 Q3 29.4 M $378 M +$7.65 M $12.84 104
2022 Q2 29.3 M $284 M -$6.67 M $9.69 87
2022 Q1 30.6 M $304 M +$11.9 M $9.94 91
2021 Q4 29.4 M $346 M +$3.17 M $11.77 99
2021 Q3 29.1 M $332 M -$3.28 M $11.39 95
2021 Q2 28.8 M $401 M -$16.7 M $13.93 98
2021 Q1 29 M $537 M -$12.1 M $18.51 100
2020 Q4 29.8 M $526 M +$27.5 M $17.67 108
2020 Q3 28.3 M $433 M +$112 M $15.32 100
2020 Q2 21.1 M $538 M +$102 M $25.48 92
2020 Q1 17.7 M $274 M +$42.1 M $15.48 71
2019 Q4 15.1 M $167 M -$60.7 K $11.06 57
2019 Q3 15.5 M $132 M -$16.9 M $8.51 50
2019 Q2 16.5 M $223 M +$1.37 M $13.54 58
2019 Q1 16.3 M $294 M +$33.9 M $18.06 53
2018 Q4 13.7 M $385 M -$47.9 M $28.09 50
2018 Q3 14.4 M $363 M -$79.1 M $25.50 53
2018 Q2 17.3 M $298 M +$298 M $17.35 41